Small Molecule Glycosylated Histone Deacetylase Inhibitors (HDACi) A targeted potential therapy for liver cancer |
8373 |
New Class of Tissue-Targeting Agents Inhibits Fibrosis, Inflammation, and Cancer GrowthA 1,000x more potent idiopathic pulmonary fibrosis (IPF) treatment than currently available |
8374 |